Abstract
The treatment of two cases of Creutzfeldt-Jakob disease with amantidine is described. The first case made a remarkable initial improvement which was sustained for two months, but then deteriorated and died. Histological examination of the brain showed changes consistent with early Creutzfeldt-Jakob disease. The second case which was clinically one of Creutzfeldt-Jakob disease has now been followed for 30 months since the start of treatment and appears to be cured. It is considered that amantidine has a definite effect in this disease and it is suggested that its mode of action, though unknown, is more likely to be metabolic than antiviral.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braham J. Jakob-Creutzfeldt disease: treatment by amantadine. Br Med J. 1971 Oct 23;4(5781):212–213. doi: 10.1136/bmj.4.5781.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galbraith A. W., Oxford J. S., Schild G. C., Potter C. W., Watson G. I. Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet. 1971 Jul 17;2(7716):113–115. doi: 10.1016/s0140-6736(71)92299-9. [DOI] [PubMed] [Google Scholar]
- Gibbs C. J., Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M., Matthews W. B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
- May W. W. Creutzfeldt-Jakob disease. 1. Survey of the literature and clinical diagnosis. Acta Neurol Scand. 1968;44(1):1–32. doi: 10.1111/j.1600-0404.1968.tb07440.x. [DOI] [PubMed] [Google Scholar]
- Nevin S. On some aspects of cerebral degeneration in later life. Proc R Soc Med. 1967 Jun;60(6):517–526. [PMC free article] [PubMed] [Google Scholar]
- Parkes J. D., Baxter R. C., Curzon G., Knill-Jones R. P., Knott P. J., Marsden C. D., Tattersall R., Vollum D. Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet. 1971 May 29;1(7709):1083–1086. doi: 10.1016/s0140-6736(71)91834-4. [DOI] [PubMed] [Google Scholar]